apoE Expression in Glomerulus and Correlation with Glomerulosclerosis Induced by Adriamycin in Rats

REFERENCES

• Attila G, Noyan A, Karabay BA, Acarturk E, Anarat A. Apolipoprotein E polymorphism in childhood nephrotic syndrome. Pediatr Nephrol. 2002;17:359–362.
   Google Scholar
• Hu P, Qin YH, Lu L, Hu B, Jing CX, Lei FY. Genetic variation of apolipoprotein E does not contribute to the lipid abnormalities secondary to childhood minimal change nephrotic syndrome. Int Urol Nephrol. 2010;42:453–460.
   PubMed Web of Science ®Google Scholar
• Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem. 2001;276:49142–49147.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yasumoto Y, Ikeda T, Takenouchi S, Sogabe A, Nosaki T. Apolipoprotein E regulates primary cultured human mesangial cell proliferation. Nephron Exp Nephrol. 2006;102:62–70.
   Google Scholar
• Calandra S, Gherardi E, Fainaru M, Guaitani A, Bartosek I. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim Biophys Acta. 1981;665:331–338.
   Google Scholar
• Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Kidney Int. 2000;58:1238–1246.
   Google Scholar
• Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P. Lipoprotein glomerulopathy treated with LDL-apheresis (heparin-induced extracorporeal lipoprotein precipitation system): A case report. J Med Case Rep. 2009;3:9311.
   PubMedGoogle Scholar
• Saito T, Sato H, Oikawa S. Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury. Nephrology. 1995;1:17–24.
   Google Scholar
• Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137–143.
   PubMed Web of Science ®Google Scholar
• Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, Dedhar S. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol. 2006;17:2164–2175.
   PubMed Web of Science ®Google Scholar
• Hu P, Qin YH, Pei J, Lei FY, Hu B, Lu L. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: A comparative study between ATRA and benazepril. Exp Mol Pathol. 2010;89:51–57.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Danilewicz M, Wagrowska-Danielwicz M. Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients. Nefrologia. 2009;29:35–41.
   PubMed Web of Science ®Google Scholar
• Kaouthar M, Faical J, Abdelmajid K, Basma H, Mohamed BH, Hafedh M. Renal α-smooth muscle actin: A new prognostic factor for lupus nephritis. Nephrology. 2009;14:499–505.
   Google Scholar
• Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediat Inflamm. 2007;2007:62641.
   PubMedGoogle Scholar
• Adan VS, Javier AM, Marisol R, Jaime GM, Dolores UB, Rita GD. Association of polymorphisms within the transforming growth factor-b1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology. 2010; 15:644–648.
   Google Scholar
• Yutaka K, Atsuhito N, Chisei RA, Ko O, Eri M, Hideoki O. Role of transforming growth factor-β/Smad signalling pathway in enhanced production of glomerular extracellular matrix in IgA nephropathy of high-serum-IgA ddY mice. Nephrology. 2002; 7:151–155.
   Google Scholar
• Hakki A, Mehmet K, Fulya YC, Serhan T, Cetin O, Akoglu E. Histopathological changes and tumour necrosis factor-α, transforming growth factor-β and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission. Nephrology. 2009;14:219–226.
   Google Scholar
• Lin CT, Xu YF, Wu JY, Chan L. Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues. J Clin Invest. 1986;78:947–958.
   Google Scholar
• Grone HJ, Walli AK, Grone E, Kramer A, Clemens MR, Seidel D. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int. 1990;37:1449–1459.
   Google Scholar
• Kaysen GA, der de Sain-van VM. New insights into lipid metabolism in the nephrotic syndrome. Kidney Int Suppl. 1999;71:18–21.
   PubMedGoogle Scholar
• Kamanna VS, Bassa BV, Ganji SH. Low density lipoproteins transactivate EGF receptor: Role in mesangial cell proliferation. Life Sci. 2008;83:595–601.
   Google Scholar
• Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H. Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int. 2010;78:69–78.
   Google Scholar
• Qin YH, Lei FY, Hu P, Pei J, Feng ZB, Pang YS. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol. 2009;24:1477–1486.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li Q, Wang L, Yang X. Simvastatin ameliorates glomerulosclerosis in adriamycin-induced-nephropathy rats. Pediatr Nephrol. 2008;23:2185–2194.
   Google Scholar
• Zhou MS, Schuman IH, Jaimes EA, Raij L. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol. 2008;295:53–59.
   PubMed Web of Science ®Google Scholar
• Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A, Lerman LO. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens. 2008; 26:1651–1660.
   PubMedGoogle Scholar
• Garcia-de-la-Puente S, Arredondo-Garcia JL, Gutierrez-Castrellon P, Bojorquez-Ochoa A, Maya ER, Perez-Martinez MP. Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders. Pediatr Nephrol. 2009;24:1205–1210.
   PubMed Web of Science ®Google Scholar